BlackRock’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.64K | Sell |
4,400
-304,643
| -99% | -$667K | ﹤0.01% | 5150 |
|
2025
Q1 | $420K | Sell |
309,043
-5,425
| -2% | -$7.38K | ﹤0.01% | 4396 |
|
2024
Q4 | $418K | Sell |
314,468
-956,553
| -75% | -$1.27M | ﹤0.01% | 4400 |
|
2024
Q3 | $1.47M | Sell |
1,271,021
-35,882
| -3% | -$41.6K | ﹤0.01% | 4036 |
|
2024
Q2 | $1.74M | Sell |
1,306,903
-94,533
| -7% | -$126K | ﹤0.01% | 3953 |
|
2024
Q1 | $2.76M | Buy |
1,401,436
+41,232
| +3% | +$81.2K | ﹤0.01% | 3830 |
|
2023
Q4 | $1.92M | Sell |
1,360,204
-1,103,839
| -45% | -$1.56M | ﹤0.01% | 3980 |
|
2023
Q3 | $3.18M | Buy |
2,464,043
+4,132
| +0.2% | +$5.33K | ﹤0.01% | 3784 |
|
2023
Q2 | $4.23M | Buy |
2,459,911
+339,110
| +16% | +$583K | ﹤0.01% | 3705 |
|
2023
Q1 | $3.84M | Buy |
2,120,801
+200,814
| +10% | +$363K | ﹤0.01% | 3670 |
|
2022
Q4 | $5.11M | Buy |
1,919,987
+372,887
| +24% | +$992K | ﹤0.01% | 3646 |
|
2022
Q3 | $5.12M | Buy |
1,547,100
+300,612
| +24% | +$995K | ﹤0.01% | 3672 |
|
2022
Q2 | $4.54M | Buy |
1,246,488
+214,489
| +21% | +$781K | ﹤0.01% | 3784 |
|
2022
Q1 | $5.25M | Buy |
1,031,999
+75,457
| +8% | +$384K | ﹤0.01% | 3851 |
|
2021
Q4 | $7.3M | Buy |
+956,542
| New | +$7.3M | ﹤0.01% | 3773 |
|